Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Head and Neck Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Sarcoma 1Lymphoma 1Lymphedema 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1Fibrosis 1Deglutition Disorders 1Congenital Abnormalities 1

Interventions

fludarabine phosphate 47Peripheral Blood Stem Cell Transplantation 39Cyclophosphamide 39Busulfan 37Tacrolimus 33Mycophenolic Acid 29Methotrexate 26Cytarabine 25Cyclosporine 25Whole-Body Irradiation 24Antilymphocyte Serum 23Radiotherapy 16Etoposide 16Filgrastim 15Methylprednisolone 11Melphalan 11Transplantation 9Cord Blood Stem Cell Transplantation 9Idarubicin 8sargramostim 7Sirolimus 7Mitoxantrone 7merphos 6Thiotepa 6Granulocyte Colony-Stimulating Factor 6Flow Cytometry 6Alemtuzumab 6fludarabine 5aldesleukin 5Gemtuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Congenital Abnormalities × Pravastatin × Clear all
NCT00840177 2023-05-03

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

SWOG Cancer Research Network

Phase 2 Completed
115 enrolled 12 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡